Ajanta Pharma Ltd
NSE:AJANTPHARM

Watchlist Manager
Ajanta Pharma Ltd Logo
Ajanta Pharma Ltd
NSE:AJANTPHARM
Watchlist
Price: 2 859.85 INR 1.24%
Market Cap: 357.2B INR
Have any thoughts about
Ajanta Pharma Ltd?
Write Note

Ajanta Pharma Ltd
Net Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Ajanta Pharma Ltd
Net Income Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
T
TORNTPHARM
M
MANKIND

Competitive Net Income Analysis
Latest Figures & CAGR of Competitors

Company Net Income CAGR 3Y CAGR 5Y CAGR 10Y
Ajanta Pharma Ltd
NSE:AJANTPHARM
Net Income
â‚ą11.8B
CAGR 3-Years
8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Net Income
â‚ą72B
CAGR 3-Years
36%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Net Income
â‚ą63.3B
CAGR 3-Years
20%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Net Income
â‚ą128.4B
CAGR 3-Years
22%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Net Income
â‚ą25.8B
CAGR 3-Years
15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
M
Mankind Pharma Ltd
NSE:MANKIND
Net Income
â‚ą24B
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ajanta Pharma Ltd's Net Income?
Net Income
11.8B INR

Based on the financial report for Sep 30, 2024, Ajanta Pharma Ltd's Net Income amounts to 11.8B INR.

What is Ajanta Pharma Ltd's Net Income growth rate?
Net Income CAGR 3Y
8%

Over the last year, the Net Income growth was 37%. The average annual Net Income growth rates for Ajanta Pharma Ltd have been 8% over the past three years .

Back to Top